← back to search

Xiaoyi Xiao

Guangzhou University of Chinese Medicine · CN
Area of research
Endocrinology, Diabetes and Metabolism · Renewable Energy, Sustainability and the Environment
Research interest
Research interests include Gut flora, Hyperuricemia, Uric acid, Immunity, Kidney, and Roseburia.
h-index
citations
118
works
8
NIH funding
primary concept
email

Recent publications

Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity
International Immunopharmacology 2025cited by 6position: middledoi
Lactobacillus acidophilus and its metabolite ursodeoxycholic acid ameliorate ulcerative colitis by promoting Treg differentiation and inhibiting M1 macrophage polarization
Frontiers in Microbiology 2024cited by 25position: middledoi
Parabacteroides distasonis-Derived Outer Membrane Vesicles Enhance Antitumor Immunity Against Colon Tumors by Modulating CXCL10 and CD8+ T Cells
Drug Design Development and Therapy 2024cited by 16position: middledoi
CT-based radiomics research for discriminating the risk stratification of pheochromocytoma using different machine learning models: a multi-center study
Abdominal Radiology 2024cited by 7position: middledoi
Kidney tea ameliorates hyperuricemia in mice via altering gut microbiota and restoring metabolic profile
Chemico-Biological Interactions 2023cited by 41position: middledoi
16S rRNA and Metagenomics Combined with UPLC-Q/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice
Drug Design Development and Therapy 2023cited by 15position: middledoi
Pogostemon cablin (Blanco) Benth granule revealed a positive effect on improving intestinal barrier function and fecal microbiota in mice with irinotecan-induced intestinal mucositis
Archives of Microbiology 2023cited by 8position: middledoi
Study on the Purification, Identification and Function Analysis of Novel Glucose-Lowering Peptides from Chickpea Protein
SSRN Electronic Journal 2023cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhi Xie · Fujian Agriculture and Forestry University7 papers (2023–2025)Pei Li · University at Buffalo, State University of New York5 papers (2023–2025)Qiongfeng Liao · Guangzhou University of Chinese Medicine5 papers (2023–2024)Rongyao Liang · Guangzhou University of Chinese Medicine5 papers (2023–2024)Xingyuan Zhang · New York University4 papers (2023–2025)Yanlong Chen · Guangzhou University of Chinese Medicine4 papers (2023–2024)Chaoying Pei · Guangzhou University of Chinese Medicine3 papers (2023–2024)Kaiwei Cai · Guangzhou University of Chinese Medicine3 papers (2023–2025)Kaiwei Cai · Guangzhou University of Chinese Medicine2 papers (2023–2023)Song Deng · Guangzhou University of Chinese Medicine2 papers (2023–2023)Xingyuan Zhang · Guangzhou University of Chinese Medicine2 papers (2023–2023)Song Deng · Guangzhou University of Chinese Medicine2 papers (2024–2025)Wenyi Huang · Guangzhou University of Chinese Medicine2 papers (2023–2024)Jinyun Wu · Guangzhou University of Chinese Medicine1 papers (2025–2025)Ye Chen · Second Affiliated Hospital of Guangzhou Medical University1 papers (2023–2023)Ye Chen · Hebei Medical University1 papers (2025–2025)Ye Chen · Massachusetts Institute of Technology1 papers (2023–2023)Ye Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)Ying Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)Ying Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)